MORGAN STANLEY - XTL BIOPHARMACEUTICALS LTD ownership

XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of XTL BIOPHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$36,417
-11.5%
40,571
-1.5%
0.00%
Q2 2023$41,167
-24.8%
41,171
-1.4%
0.00%
Q1 2023$54,720
+5.2%
41,771
-2.8%
0.00%
Q4 2022$51,995
+4.0%
42,971
-5.1%
0.00%
Q3 2022$50,000
-32.4%
45,271
-7.2%
0.00%
Q2 2022$74,000
-27.5%
48,771
-1.0%
0.00%
Q1 2022$102,000
-27.7%
49,271
-3.5%
0.00%
Q4 2021$141,000
-37.6%
51,071
-1.2%
0.00%
Q3 2021$226,000
+4.6%
51,671
-4.4%
0.00%
Q2 2021$216,000
+20.0%
54,064
+0.1%
0.00%
Q1 2021$180,000
+4.7%
54,026
-4.9%
0.00%
Q4 2020$172,000
+91.1%
56,823
+19.8%
0.00%
Q3 2020$90,000
+34.3%
47,431
+13.4%
0.00%
Q2 2020$67,000
+42.6%
41,831
+4.8%
0.00%
Q1 2020$47,000
-6.0%
39,931
+8.4%
0.00%
Q4 2019$50,000
+2.0%
36,831
+1.9%
0.00%
Q3 2019$49,000
-31.9%
36,132
+0.3%
0.00%
Q2 2019$72,000
-12.2%
36,032
+3.7%
0.00%
Q1 2019$82,000
+43.9%
34,732
+4.8%
0.00%
Q4 2018$57,000
+9.6%
33,132
+40.8%
0.00%
Q3 2018$52,000
+40.5%
23,532
+16.7%
0.00%
Q2 2018$37,000
+37.0%
20,161
+27.1%
0.00%
Q1 2018$27,000
+8.0%
15,861
+47.4%
0.00%
Q4 2017$25,000
+13.6%
10,761
+17.5%
0.00%
Q3 2017$22,000
+4.8%
9,160
+37.5%
0.00%
Q2 2017$21,000
-30.0%
6,660
-40.1%
0.00%
Q1 2017$30,00011,1200.00%
Other shareholders
XTL BIOPHARMACEUTICALS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Noked Capital LTD 198,888$794,0000.20%
Noked Israel Ltd 198,888$794,0000.20%
SteelPeak Wealth, LLC 11,671$47,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 54,064$216,0000.00%
Renaissance Technologies 37,187$148,0000.00%
View complete list of XTL BIOPHARMACEUTICALS LTD shareholders